Abstract
Aim
HIV-associated diarrhea is common in HIV/AIDS patients in developing countries. An earlier uncontrolled study showed that a nutritional product made from bovine colostrum (ColoPlus®) alleviates HIV-associated diarrhea. We performed a randomized single-blind controlled trial of addition of colostrum-based supplement (ColoPlus®) to standard anti-diarrhea treatment in HIV/AIDS patients with diarrhea.
Methods
Eighty-seven adult patients with HIV-associated diarrhea were recruited at Gulu Hospital and four community clinics in Northern Uganda. Forty-five patients were randomized to receive 50 g of colostrum-based supplement twice a day for 4 weeks in addition to standard anti-diarrhea treatment, and 42 patients received standard anti-diarrhea treatment alone. Patients were followed up for 9 weeks. Daily stool frequency was recorded, and body weight and body mass index were evaluated at weeks 1, 4 and 9. Baseline CD4+ count was measured at baseline and at week 9.
Results
Mean daily stool frequency decreased by 79% from 7.5 to 1.3 motions over the study period in patients on colostrum-based supplement, compared to a 58% reduction in controls (p < 0.001). Self-reported fatigue was reduced by 85% in patients on colostrum-based supplement by week 9 compared to 43% reduction amongst controls (p < 0.001). Patients on colostrum-based supplement had 11% increase (p < 0,001) in mean body weight and body mass index by week 9, but no changes were observed in control subjects. Mean CD4+ count increased by 14% for patients on colostrum-based supplement, in contrast to 12% decrease in controls (p < 0.001).
Conclusions
This study shows that addition of colostrum-based supplement to standard therapy is effective in treatment of HIV-associated diarrhea.
Similar content being viewed by others
References
Lacor 2008. St. Mary’s Hospital Lacor annual report 2007/2008, p29. www.lacorhospital.org
MOH 2003. Ministry of Health HIV/AIDS Policy, 2003.
Rump JA, Arndt R, Arnold A, et al. Treatment of diarrhea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Invest. 1992;70:588–94.
Pakkanen R, Aalto J. Growth factors and antimicrobial factors of bovine colostrums. Int Dairy J. 1997;7:285–97.
Plettenberg A, Stoehr A, Stellbrink HJ, Albrecht H, Meigel W. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clin Invest. 1993;71:42–5.
Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13:348–54.
Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhoea in AIDS patients. AIDS. 1990;4:581–4.
Beth L, Ungar P, Douglas J. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology. 1990;98:486–9.
Florén C-H, Chinenye S, Elfstrand L, Hagman C, Ihse I. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand J Gastroenterol. 2006;41:682–6.
Elfstrand L, Lindmark-Månsson H, Paulsson M, Nyberg L, Åkesson B. Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing. Int Dairy J. 2002;12:879–87.
Craig RM, Carlson S, Ehrenpreis E. Acquired immunodeficiency syndrome enteropathy: a perspective. Compr Ther. 1995;21:184–8.
Acknowledgements
This work was supported by the Swedish Embassy in Uganda and Gulu Women Economic Development and Globalization, Uganda.
Conflict of interest
The authors declare that Claes-Henrik Florén and Lidia Elfstrand are on the advisory board of ColoPlus AB, without up to now getting any financial compensation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaducu, F.O., Okia, S.A., Upenytho, G. et al. Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial. Indian J Gastroenterol 30, 270–276 (2011). https://doi.org/10.1007/s12664-011-0146-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-011-0146-0